Related Experiment Videos
Serum fructosamine and glycated haemoglobin measurements in diabetic control
Insights
Serum fructosamine offers a fast, easy, and cost-effective method for monitoring glycaemic control in diabetic children. This reliable indicator parallels glycated haemoglobin (HbA1) levels, providing timely insights into blood sugar management.
Area of Science:
- Pediatrics
- Endocrinology
- Clinical Chemistry
Background:
- Diabetic children require consistent monitoring of glycaemic control.
- Glycated haemoglobin (HbA1) is a standard but time-consuming marker.
- Alternative markers for glycaemic control are needed for efficient patient management.
Purpose of the Study:
- To evaluate serum fructosamine as a reliable indicator of glycaemic control in diabetic children.
- To compare the efficacy of fructosamine with glycated haemoglobin (HbA1) and home glucose monitoring.
- To assess the utility of fructosamine for early detection of glycaemic control changes.
Main Methods:
- Serum fructosamine and HbA1 levels were measured in capillary samples from diabetic and non-diabetic children.
- Clinical assessment and home glucose monitoring data were used to evaluate glycaemic control.
- Correlations between fructosamine, HbA1, and average daily glucose values were analyzed.
Main Results:
- Serum fructosamine showed a significant correlation with HbA1 and 30-day average glucose values.
- HbA1 correlated with 60-day average glucose values.
- Changes in fructosamine levels paralleled HbA1, indicating its potential for early detection of glycaemic shifts.
Conclusions:
- Serum fructosamine is a reliable and practical alternative to HbA1 for assessing glycaemic control in pediatric diabetes.
- Fructosamine offers advantages in speed, technical ease, and cost.
- This marker can provide advance indication of deteriorating or improving glycaemic control in children with diabetes.
Abstract:
Serum fructosamine and glycated haemoglobin (HbA1) were measured in capillary samples from diabetic children and compared with samples from non-diabetic children. Glycaemic control was assessed clinically and by average daily glucose values recorded by home monitoring. Fructosamine correlated with HbA1 and with average glucose values measured over 30 days. HbA1 also correlated with average glucose values measured over 60 days. Changes in fructosamine with time tended to parallel those of HbA1, and advance indication of deteriorating or improving glycaemic control was possible by observing changes in these. Fructosamine has many advantages over HbA1 measurement such as speed, technical ease, and low cost, and is a reliable alternative to HbA1 estimation as an indication of glycaemic control.